Authors:
ATKINSON K
NIVISONSMITH I
DODDS A
CONCANNON A
MILLIKEN S
DOWNS K
Citation: K. Atkinson et al., A COMPARISON OF THE PATTERN OF INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION BEFORE AND AFTER THE INTRODUCTION OF PROPHYLACTIC GANCICLOVIR THERAPY IN 1989, Bone marrow transplantation, 21(7), 1998, pp. 691-695
Citation: J. Low et al., INR DISCREPANCIES WITH A RECOMBINANT THROMBOPLASTIN IN 2 PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME, Thrombosis and haemostasis, 1997, pp. 2861-2861
Authors:
ARTHUR CK
ENNO A
FIRKIN F
MA D
ILAND H
CONCANNON A
YOUNG G
SHAW P
GALLO J
HERTZBERG M
Citation: Ck. Arthur et al., A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C), Blood, 88(10), 1996, pp. 2291-2291
Authors:
ATKINSON K
DOWNS K
CONCANNON A
MILLIKEN S
Citation: K. Atkinson et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML) - REPLY, Australian and New Zealand Journal of Medicine, 26(4), 1996, pp. 571-571
Authors:
ATKINSON K
DOWNS K
DODDS A
CONCANNON A
MILLIKEN S
Citation: K. Atkinson et al., 5-YEAR LEUKEMIA-FREE SURVIVAL OF 72-PERCENT AND 77-PERCENT FOR EARLY-STAGE ACUTE AND CHRONIC MYELOID-LEUKEMIA TREATED BY HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Australian and New Zealand Journal of Medicine, 26(1), 1996, pp. 54-58
Authors:
BIGGS JC
ATKINSON KA
BOOKER V
CONCANNON A
DART GW
DODDS A
DOWNS K
SZER J
TURNER J
WORTHINGTON R
Citation: Jc. Biggs et al., PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF THE IN-VIVO USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN BONE-MARROW TRANSPLANTATION FROM HLA-IDENTICAL SIBLING DONORS, Bone marrow transplantation, 15(1), 1995, pp. 129-134
Authors:
ATKINSON K
DODDS A
MILLIKEN S
CONCANNON A
FAY K
HARRIS M
FLECKNOEBROWN S
LIND D
MCKINLEY R
RUTOVITZ J
ROSENFELD D
HARVEY M
DOWNS K
FLATTERY D
SONG J
GREEN A
QUIGLEY V
HAWKINS T
Citation: K. Atkinson et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY - TREATMENT-RELATED MORTALITY OF 2-PERCENT, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 483-489
Authors:
BRADSTOCK K
MATTHEWS J
BENSON E
PAGE F
BISHOP J
PIDCOCK M
GALLO J
ROSENFELD D
KWAN Y
TANG RLP
ENNO A
SELDON N
GIBSON J
ILAND K
JOSHUA D
KRONENBERG H
VINCENT P
YOUNG G
MANOHARAN A
ATKINSON K
BIGGS J
CONCANNON A
DODDS A
BENSON W
GOTTLIEB D
KOUTTS J
LEE C
TAYLOR K
COBCROFT R
GILL D
BUNCE I
DURRANT S
GILLETT A
HILL G
ROESSER P
ROONEY K
KIMBER R
LOWENTHAL R
DALE B
JUTTNER C
FIRKIN B
SZER J
VANDERWEYDEN M
WHITESIDE M
COOPER I
DING J
JANUSZEWICZ E
WOLF M
FOX R
GREEN M
FIRKIN F
LEAHY M
HERRMANN R
Citation: K. Bradstock et al., PROGNOSTIC VALUE OF IMMUNOPHENOTYPING IN ACUTE MYELOID-LEUKEMIA, Blood, 84(4), 1994, pp. 1220-1225
Authors:
CONCANNON A
KEENEY S
MATHEWSON A
BEZ R
LOMBARDI C
Citation: A. Concannon et al., 2-DIMENSIONAL NUMERICAL-ANALYSIS OF FLOATING-GATE EEPROM DEVICES, I.E.E.E. transactions on electron devices, 40(7), 1993, pp. 1258-1262